Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
11.90
+0.70 (6.25%)
At close: Oct 26, 2026, 4:00 PM EDT
11.89
-0.01 (-0.08%)
After-hours: Oct 26, 2026, 7:35 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $834.27 million as of October 26, 2026. Its market cap has decreased by 7.69% in one year.
Market Cap
834.27M
Enterprise Value
790.23M
1-Year Change
-7.69%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $834.27M, an increase of 547.45%. That is a compound annual growth rate of 7.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 802.10M | -30.08% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 884.56M |
| Alumis | 877.57M |
| Aktis Oncology | 874.89M |
| Obsidian Therapeutics | 863.58M |
| Alto Neuroscience | 862.15M |
| Kura Oncology | 854.91M |
| Arbutus Biopharma | 830.96M |
| Inventiva | 809.65M |